POS-365 PIOGLITAZONE REDUCES MORTALITY AND ADVERSE EVENTS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: NATIONAL COHORT STUDY

POS-365 PIOGLITAZONE REDUCES MORTALITY AND ADVERSE EVENTS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: NATIONAL COHORT STUDY

Bibliographic Details
Main Authors:	H.Y. Yang MD, C.L. Yen
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024921005283

Similar Items

Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis
by: Chin-Hsiao Tseng
Published: (2018-09-01)

The Risk of Adverse Events in Patients With Polycystic Kidney Disease With Advanced Chronic Kidney Disease
by: Sonali de Chickera, et al.
Published: (2018-05-01)

POS-371 SERUM CATALYTIC IRON LEVEL IS ASSOCIATED WITH MAJOR ADVERSE KIDNEY EVENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
by: S. Divyaveer, et al.
Published: (2021-04-01)

The use of venous Doppler to predict adverse kidney events in a general ICU cohort
by: Rory Spiegel, et al.
Published: (2020-10-01)

POS-522 MORTALITY AND CARDIOVASCULAR EVENTS IN ADULTS WITH KIDNEY FAILURE AFTER MAJOR NON-CARDIAC SURGERY: A POPULATION-BASED COHORT STUDY
by: T. HARRISON, et al.
Published: (2021-04-01)

Metformin and pioglitazone are effective in reducing the levels of leptin and omentin
Published: (2013-03-01)

Office 365 Migrating and Managing Your Business in the Cloud
Published: (2013)

Pioglitazone Is Associated with Lower Major Adverse Cardiovascular and Cerebrovascular Events than DPP4-Inhibitors in Diabetic Patients with End-Stage Renal Disease: A Taiwan Nationwide Cohort Study, 2006–2016
by: Min-Hao Lin, et al.
Published: (2020-11-01)

Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study
by: Sunil Gupta, et al.
Published: (2015-01-01)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
by: Holl, et al.
Published: (2014-07-01)

Repetition with revision : Suzan-Lori Parks' 365 days/365 plays and the new theatre festival
by: Leadley, Allison
Published: (2010)

Repetition with revision : Suzan-Lori Parks' 365 days/365 plays and the new theatre festival
by: Leadley, Allison
Published: (2010)

Repetition with revision : Suzan-Lori Parks' 365 days/365 plays and the new theatre festival
by: Leadley, Allison
Published: (2010)

Does Statin Therapy Reduce the Risks of Mortality and Major Adverse Cardiac and Cerebrovascular Events in Young Adults with End-Stage Renal Disease? Population-Based Cohort Study
by: Ya-Lien Cheng, et al.
Published: (2021-05-01)

Medical adverse events in the US 2018 mortality data
by: Petteri Oura
Published: (2021-12-01)

60x365: Compositions For the Internet
by: Morneau, David
Published: (2011)

Angiopoietin-2 as a Prognostic Biomarker of Major Adverse Cardiovascular Events and All-Cause Mortality in Chronic Kidney Disease.
by: Yi-Chun Tsai, et al.
Published: (2015-01-01)

Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial.
by: Bancha Satirapoj, et al.
Published: (2018-01-01)

Pioglitazone Attenuates Cystic Burden in the PCK Rodent Model of Polycystic Kidney Disease
by: Bonnie L. Blazer-Yost, et al.
Published: (2010-01-01)

DNA oxidation and superoxide dismutase in the kidney of diabetic animals: effects of pioglitazone and repaglinide
by: Gumieniczek Anna, et al.
Published: (2006-09-01)

Association of digoxin with mortality in patients with advanced chronic kidney disease: A population-based cohort study.
by: Lii-Jia Yang, et al.
Published: (2021-01-01)

Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study
by: Navdeep Tangri, et al.
Published: (2021-05-01)

Changes in metabolic parameters and adverse kidney and cardiovascular events during glomerulonephritis and renal vasculitis treatment in patients with and without diabetes mellitus
by: Cynthia C. Lim, et al.
Published: (2021-06-01)

Efficacy of Early Combined Therapy with Metformin and Pioglitazone in Patients with Diabetes Mellitus Type 2
by: V.I. Pankiv
Published: (2012-03-01)

Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
by: Jingxuan Lian, et al.
Published: (2021-04-01)

Does a Supplemental Low-Protein Diet Decrease Mortality and Adverse Events After Commencing Dialysis? A Nationwide Cohort Study
by: Chieh-Li Yen, et al.
Published: (2018-08-01)

Pioglitazone: Hype and hope
by: S S Jadhav, et al.
Published: (2014-01-01)

Pioglitazone: Indian perspective
by: Rishi Shukla, et al.
Published: (2011-01-01)

Statin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study
by: Colman Siu Cheung Fung, et al.
Published: (2017-06-01)

Reducing preventable adverse drug events in hospital settings
by: Ramos, Gregg (Gregg Allen)
Published: (2008)

Archaeologists and earthquakes: the case of 365 A.D.
by: A. Di Vita
Published: (1995-06-01)

ЕЛЕКТРОННЕ НАВЧАННЯ ЗАСОБАМИ MICROSOFT OFFICE 365
by: Olena Borysiuk
Published: (2018-10-01)

Pioglitazone Improves the Function of Human Mesenchymal Stem Cells in Chronic Kidney Disease Patients
by: Yeo Min Yoon, et al.
Published: (2019-05-01)

POS-331 ASSOCIATION OF IMPAIRED KIDNEY FUNCTION WITH MORTALITY IN RURAL UGANDA: RESULTS OF A GENERAL POPULATION COHORT STUDY
by: R. Kalyesubula, et al.
Published: (2021-04-01)

Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
by: Pravesh Kumar Bundhun, et al.
Published: (2017-10-01)

Cardiovascular Outcomes in Patients With Previous Myocardial Infarction and Mild Diabetes Mellitus Following Treatment With Pioglitazone
by: Masanori Asakura, et al.
Published: (2018-10-01)

Efficiency and Safety of Metformine and Pioglitazone in Patients with Coronary Heart Disease and Diabetes Mellitus Type 2
by: Z.A. Shaienko, et al.
Published: (2015-03-01)

Care complexity individual factors associated with adverse events and in-hospital mortality.
by: Jordi Adamuz, et al.
Published: (2020-01-01)

Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism
by: Julia C. Cambron, BS, et al.
Published: (2020-06-01)

Blood Transfusion and Adverse Graft-related Events in Kidney Transplant Patients
by: David Massicotte-Azarniouch, et al.
Published: (2021-04-01)

Cannot write session to /tmp/vufind_sessions/sess_b06u3gbgdoacl525hnc7e4elvl